SCHEMBL14743644

SCHEMBL14743644

CN(CC(=O)NCc1ccnnc1)c1cc(C(=O)O)cc2cc(Cl)cc(Cl)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
KMT2A Q03164 4/20 0.38
THRB P10828 1/20 0.36
POLB P06746 1/20 0.36
CHRM4 P08173 1/20 0.35
MEN1 O00255 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
CDK2 P24941 1/20 0.34
GSK3B P49841 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14743911 0.91 ALDH1A1 (0.39) TDP1KMT2ATHRBPOLBCHRM4
SCHEMBL14743576 0.90 KMT2A (0.48) TDP1KMT2AMEN1ALDH1A1MAPT
SCHEMBL14743424 0.90 TDP1 (0.52) TDP1KMT2APOLBMEN1ALDH1A1
SCHEMBL14743033 0.87 TDP1 (0.41) TDP1KMT2ATHRBPOLBMEN1
SCHEMBL14743819 0.84 LMNA (0.34) TDP1KMT2ATHRBCHRM4ALDH1A1
SCHEMBL14742993 0.84 GAA (0.34) TDP1KMT2ATHRBMEN1ALDH1A1
SCHEMBL14743626 0.83 GAA (0.48) KMT2APOLBMEN1ALDH1A1MAPT
SCHEMBL14743642 0.82 HPGDS (0.37) TDP1CHRM4ALDH1A1OPRM1OPRL1
SCHEMBL14743068 0.81 PSMD14 (0.38) KMT2APOLBCHRM4MEN1ALDH1A1
SCHEMBL14743411 0.81 TDP1 (0.50) TDP1KMT2APOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013030358-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2013-03-07 WO claimed
WO-2013030358-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2013-03-07 WO disclosed